Clinical Trial Update: Prophylaxis With Caspofungin in High-Risk Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating prophylaxis with caspofungin to prevent fungal infections in high-risk liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Sponsor: Grupo de Estudio de Infecciones en Transplantados | Conditions: Liver Transplantation, Fungal Infection | Phase 2 | Status: UNKNOWN